These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Schindowski K, Bretteville A, Leroy K, Bégard S, Brion JP, Hamdane M, Buée L. Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359 [Abstract] [Full Text] [Related]
3. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S, Schneider M, Hamdane M, Müller CE, Buée L, Blum D. Neurobiol Aging; 2014 Sep; 35(9):2079-90. PubMed ID: 24780254 [Abstract] [Full Text] [Related]
4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H, Grigoriadis N, Eldar-Levy H, Avital A, Rozenstein L, Touloumi O, Behar L, Ben-Hur T, Avraham Y, Berry E, Segal M, Ginzburg I, Abramsky O. Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [Abstract] [Full Text] [Related]
5. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease. Lo AC, Iscru E, Blum D, Tesseur I, Callaerts-Vegh Z, Buée L, De Strooper B, Balschun D, D'Hooge R. J Alzheimers Dis; 2013 Jul; 37(1):109-25. PubMed ID: 23788007 [Abstract] [Full Text] [Related]
6. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. Burnouf S, Martire A, Derisbourg M, Laurent C, Belarbi K, Leboucher A, Fernandez-Gomez FJ, Troquier L, Eddarkaoui S, Grosjean ME, Demeyer D, Muhr-Tailleux A, Buisson A, Sergeant N, Hamdane M, Humez S, Popoli P, Buée L, Blum D. Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852 [Abstract] [Full Text] [Related]
7. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Burlot MA, Braudeau J, Michaelsen-Preusse K, Potier B, Ayciriex S, Varin J, Gautier B, Djelti F, Audrain M, Dauphinot L, Fernandez-Gomez FJ, Caillierez R, Laprévote O, Bièche I, Auzeil N, Potier MC, Dutar P, Korte M, Buée L, Blum D, Cartier N. Hum Mol Genet; 2015 Nov 01; 24(21):5965-76. PubMed ID: 26358780 [Abstract] [Full Text] [Related]
8. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Van der Jeugd A, Ahmed T, Burnouf S, Belarbi K, Hamdame M, Grosjean ME, Humez S, Balschun D, Blum D, Buée L, D'Hooge R. Neurobiol Learn Mem; 2011 Mar 01; 95(3):296-304. PubMed ID: 21167950 [Abstract] [Full Text] [Related]
9. Exercise during pregnancy mitigates Alzheimer-like pathology in mouse offspring. Herring A, Donath A, Yarmolenko M, Uslar E, Conzen C, Kanakis D, Bosma C, Worm K, Paulus W, Keyvani K. FASEB J; 2012 Jan 01; 26(1):117-28. PubMed ID: 21948247 [Abstract] [Full Text] [Related]
10. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies. Leem YH, Lim HJ, Shim SB, Cho JY, Kim BS, Han PL. J Neurosci Res; 2009 Aug 15; 87(11):2561-70. PubMed ID: 19360903 [Abstract] [Full Text] [Related]
11. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation. Liu HL, Zhao G, Cai K, Zhao HH, Shi LD. Behav Brain Res; 2011 Apr 15; 218(2):308-14. PubMed ID: 21192984 [Abstract] [Full Text] [Related]
12. Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22. Kacířová M, Železná B, Blažková M, Holubová M, Popelová A, Kuneš J, Šedivá B, Maletínská L. J Neuroinflammation; 2021 Jun 22; 18(1):141. PubMed ID: 34158075 [Abstract] [Full Text] [Related]
13. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice. García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C. J Alzheimers Dis; 2011 Jun 22; 24(3):421-54. PubMed ID: 21297257 [Abstract] [Full Text] [Related]
14. MRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance. García-Gómez BE, Fernández-Gómez FJ, Muñoz-Delgado E, Buée L, Blum D, Vidal CJ. J Mol Neurosci; 2016 Apr 22; 58(4):411-5. PubMed ID: 26697857 [Abstract] [Full Text] [Related]
15. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study. Chong SA, Benilova I, Shaban H, De Strooper B, Devijver H, Moechars D, Eberle W, Bartic C, Van Leuven F, Callewaert G. Neurobiol Dis; 2011 Dec 22; 44(3):284-91. PubMed ID: 21807097 [Abstract] [Full Text] [Related]
16. Loss of medial septum cholinergic neurons in THY-Tau22 mouse model: what links with tau pathology? Belarbi K, Burnouf S, Fernandez-Gomez FJ, Desmercières J, Troquier L, Brouillette J, Tsambou L, Grosjean ME, Caillierez R, Demeyer D, Hamdane M, Schindowski K, Blum D, Buée L. Curr Alzheimer Res; 2011 Sep 22; 8(6):633-8. PubMed ID: 21605043 [Abstract] [Full Text] [Related]
17. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy. Köhler C, Bista P, Götz J, Schröder H. Brain Res; 2010 Aug 06; 1347():111-24. PubMed ID: 20513372 [Abstract] [Full Text] [Related]
18. Observations in THY-Tau22 mice that resemble behavioral and psychological signs and symptoms of dementia. Van der Jeugd A, Blum D, Raison S, Eddarkaoui S, Buée L, D'Hooge R. Behav Brain Res; 2013 Apr 01; 242():34-9. PubMed ID: 23247080 [Abstract] [Full Text] [Related]
19. Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet. Gratuze M, Julien J, Morin F, Marette A, Planel E. Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct 03; 79(Pt B):452-461. PubMed ID: 28779908 [Abstract] [Full Text] [Related]